ADGRA1: A GPCR Target for Therapeutic Agents (G84435)

Target Name: ADGRA1

NCBI ID: G84435

ADGRA1

ADGRA1: A GPCR Target for Therapeutic Agents

The Adhesion G protein-coupled receptor A1 (ISOFORM 1) is a transmembrane protein that plays a crucial role in various physiological processes in the body. It is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that mediate various signaling pathways in various cell types. GPCR signaling pathways have been implicated in many diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. As a result, targeting GPCR signaling pathways has become an attractive area of 鈥嬧?媟esearch in recent years.

ADGRA1: Structure and Function

ADGRA1 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and skin. It is highly homogeneous and has a single transmembrane domain. The protein has a unique structure that consists of an extracellular domain, a transmembrane domain, and an intracellular domain.

The extracellular domain of ADGRA1 is composed of a N-terminal伪-helix and a C-terminal尾-sheet. The N-terminal region contains a putative N-terminal receptor domain that is involved in ligand binding and signal transduction after ligand binding. guide. The C-terminal region contains a transmembrane domain that is known as the extracellular domain-Ti domain. This region contains a unique type of protein structure called a 尾-sheet that is involved in the formation of a transmembrane domain-尾-sheet complex.

The transmembrane domain of ADGRA1 is composed of a variable number of 尾-strands that are involved in the formation of an acidic transmembrane environment. The 尾-strands are responsible for maintaining the transmembrane integrity of the protein and for mediating various signaling pathways.

The intracellular domain of ADGRA1 is composed of a unique protein structure called a nucleotide-binding oligomerization (NBO) domain. This domain is involved in the interaction with various intracellular signaling molecules, including tyrosine kinases.

ADGRA1 signaling pathways

ADGRA1 is involved in various signaling pathways, including the regulation of cell adhesion, the regulation of ion channels, and the regulation of cytoskeletal dynamics.

One of the well-known signaling pathways that is involved in ADGRA1 is the regulation of cell adhesion. ADGRA1 is known to play a role in the regulation of tight junctions, which are responsible for maintaining the integrity of the intercellular space and for ensuring the proper exchange of nutrients and waste products between cells.

ADGRA1 is also involved in the regulation of ion channels. In particular, it is known to play a role in the regulation of potassium channels, which are involved in the regulation of electrical potential in the cell membrane.

In addition to its role in cell adhesion and ion channels, ADGRA1 is also involved in the regulation of cytoskeletal dynamics. It is known to play a role in the regulation of actin dynamics and in the regulation of microtubule dynamics.

Drug targeting ADGRA1

ADGRA1 is a drug target of great interest due to its involvement in various signaling pathways. Several drugs have been developed to target ADGRA1, including inhibitors of tyrosine kinases, such as vasodilators and anti-inflammatory drugs, and inhibitors of calcium channels, such as phenylpropionic acid drugs. In addition, there are studies exploring ADGRA1 as a potential drug for the treatment of neurodegenerative diseases, tumors, and immune diseases.

Conclusion

ADGRA1 is a GPCR that plays a crucial role in various physiological processes in the body. Its unique structure and function make it an attractive drug target for the development of new therapeutic agents for a variety of diseases. Further research is needed to fully understand the role of ADGRA1 in

Protein Name: Adhesion G Protein-coupled Receptor A1

Functions: Orphan receptor

The "ADGRA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADGRA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets